2 hours Legend Biotech (NASDAQ:LEGN) Stock Rating Reaffirmed by HC WainwrightMarketBeat
HC Wainwright reissued a “buy” rating and set a $73.00 target price on shares of Legend Biotech in a research note on Wednesday.
Biotech · Nasdaq 100 · Science
X